| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |